Medline, the world's largest supplier of medical-surgical products, has recalled more than 1,000 hospital beds, along with associated rails and mattresses, due to serious fire and patient entrapment hazards. The U.S. Food and Drug Administration (FDA) announced the recall, which has been linked to seven deaths and 35 serious injuries.

The initial recall was issued on October 14, but the warning was expanded on November 8 to include the higher number of reported fatalities and injuries. This marks a significant increase from the two deaths and 16 injuries previously cited by the FDA.

The affected products were distributed across the United States and Canada between 2011 and 2026 to durable medical equipment providers, long-term care facilities, and directly to consumers. Medline has decided to discontinue these product lines entirely but is offering a repair and replacement program for eligible products purchased within the last five years.

Two primary safety risks have been identified with the recalled beds. First, overheating electrical components, including hand-control pendants, control boxes, and motors, can lead to fires. This overheating can be caused by excessive loading, jammed motors, damaged controls, liquid exposure, or the use of incompatible accessories, potentially resulting in smoke, sparks, melting, burns, or fires.

Second, patients are at risk of entrapment or suffocation due to loose or unstable bed rails, incompatible accessories, or hand-control pendants becoming positioned beneath the patient. The FDA has published an eight-page list of affected product numbers to help facilities and caregivers identify the recalled items.

Health officials advise users of the affected products to immediately unplug the beds from electrical outlets and to avoid using extension cords. They recommend plugging the bed in only when adjusting it for a patient and unplugging it when not in use for repositioning.

Medline supplies a wide range of medical products, including hospital beds, mattresses, and personal protective equipment, to healthcare systems across North America. The FDA encourages anyone who has experienced injuries or quality issues with these products to report them through its MedWatch Adverse Event Reporting program.